• Personal Stories

‘Being open will help bring awareness’: Meet the fashion vlogger who went public on her diagnosis

Style vlogger Adobea Obeng decided to open up about her cancer diagnosis on her YouTube channel earlier this year. Style vlogger Adobea Obeng decided to open up about her cancer diagnosis on her YouTube channel earlier this year.

16 November 2022

• Science & Technology
• Policy & Insight

Cancer research could revive the UK’s ailing public finances

When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications. When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications.

16 November 2022

• Health & Medicine

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales. The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

14 November 2022

• For Researchers

Thinking outside the chromosome – how ecDNA is challenging conventional thinking

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study? What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?

11 November 2022

• Health & Medicine
• Science & Technology

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

11 November 2022

• Health & Medicine

The rise of the ‘long-waiter’ – why cancer waiting times are showing the pressure more than ever before

10 November 2022

• Science & Technology

TRACERx EVO, a new programme to transform lung cancer research

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

9 November 2022

• Science & Technology

The Nobel Prize winner helping us treat children's cancers

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

8 November 2022

• Science & Technology
• Health & Medicine

Changes to chromosomes impact how children's brain tumours respond to treatment

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

4 November 2022

• Policy & Insight

Why consistent and funded cancer policies are key to improving cancer survival

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

1 November 2022